JFNIX
Price
$68.93
Change
-$1.25 (-1.78%)
Updated
Sep 25 closing price
Net Assets
4.49B
LHCIX
Price
$19.45
Change
-$0.24 (-1.22%)
Updated
Sep 25 closing price
Net Assets
7.64M
Interact to see
Advertisement

JFNIX vs LHCIX

Header iconJFNIX vs LHCIX Comparison
Open Charts JFNIX vs LHCIXBanner chart's image
Janus Henderson Global Life Sciences I
Price$68.93
Change-$1.25 (-1.78%)
VolumeN/A
Net Assets4.49B
Lord Abbett Health Care I
Price$19.45
Change-$0.24 (-1.22%)
VolumeN/A
Net Assets7.64M
JFNIX vs LHCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCIX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Hold and LHCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.49B vs. LHCIX (7.64M). LHCIX pays higher dividends than JFNIX: LHCIX (0.56) vs JFNIX (0.39). JFNIX was incepted earlier than LHCIX: JFNIX (16 years) vs LHCIX (6 years). LHCIX (3.09) is less costly to investors than JFNIX (0.77). LHCIX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). JFNIX has a lower initial minimum investment than LHCIX: JFNIX (2500) vs LHCIX (1000000). LHCIX annual gain was more profitable for investors over the last year : -2.92 vs. JFNIX (-12.39). JFNIX return over 5 years is better than : 8.34 vs. LHCIX (3.59).
JFNIXLHCIXJFNIX / LHCIX
Total Expense Ratio0.770.7899%
Annual Report Gross Expense Ratio0.773.0925%
Fund Existence16 years6 years-
Gain YTD3.1761.757181%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49B7.64M58,712%
Annual Yield % from dividends0.390.5670%
Returns for 1 year-12.39-2.92425%
Returns for 3 years21.3025.2184%
Returns for 5 years8.343.59233%
Returns for 10 years39.28N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLUEX12.57N/A
N/A
Lazard US Equity Concentrated R6
FBDIX143.61N/A
N/A
Franklin Biotechnology Discovery A
CFSIX21.84N/A
N/A
Touchstone Sands Capital Select Growth Y
TIBRX31.71N/A
N/A
Thornburg Investment Income Builder R3
BIRDX8.53N/A
N/A
iShares Developed Real Estate Idx Instl